| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgery (SP, DH, YS), Pathology (DJ), and Radiology (KS, JT), York Hospital, York, Pennsylvania.
Correspondence: Address correspondence and reprint requests to: Steven Pandelidis, MD, Apple Hill Surgical Associates, 25 Monument Rd., Suite 220,York, PA 17403; Fax: 717-741-3604; E-mail: sjasj{at}aol.com
Background: Image-guided percutaneous biopsy has largely replaced excisional biopsy of mammographic lesions. Vacuum-assisted core biopsy has improved sampling of such lesions. The objectives of this study were to define the accuracy of the vacuum-assisted 11-gauge stereotactic core biopsy in sampling of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS) and to define histologic and mammographic features of target lesions, which predict sampling errors.
Methods: Between October 1996 and March 2000, 1341 patients underwent stereotactic 11-gauge vacuum-assisted biopsy. Patients with ADH or DCIS were encouraged to undergo excisional biopsy.
Results: Surgical excision of 37 ADH lesions revealed 5 missed DCIS lesions and 1 missed invasive cancer. Twelve of 91 DCIS lesions were upstaged to invasive cancer upon excision. The underestimation rate was highest in patients with DCIS when the target lesion for biopsy was a zone of calcifications >1.5 cm. No correlation existed between the histologic features of DCIS lesions diagnosed by stereotactic biopsy and the presence of infiltrating disease on excision.
Conclusions: Vacuum-assisted 11-gauge stereotactic core biopsy understages 13.2% and 13.5% of DCIS and ADH lesions, respectively. In patients with DCIS found by stereotactic biopsy, a target zone of calcifications >1.5 cm is associated with a higher underestimation rate of infiltrating disease.
Key Words: 11-gauge vacuum-assisted core biopsy Mammographic Stereotactic Breast lesions
This article has been cited by other articles:
![]() |
P. R. Eby, J. E. Ochsner, W. B. DeMartini, K. H. Allison, S. Peacock, and C. D. Lehman Frequency and Upgrade Rates of Atypical Ductal Hyperplasia Diagnosed at Stereotactic Vacuum-Assisted Breast Biopsy: 9-Versus 11-Gauge Am. J. Roentgenol., January 1, 2009; 192(1): 229 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Eby, J. E. Ochsner, W. B. DeMartini, K. H. Allison, S. Peacock, and C. D. Lehman Is Surgical Excision Necessary for Focal Atypical Ductal Hyperplasia Found at Stereotactic Vacuum-Assisted Breast Biopsy? Ann. Surg. Oncol., November 1, 2008; 15(11): 3232 - 3238. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sohn, Z. Arthurs, G. Herbert, J. Keylock, J. Perry, M. Eckert, D. Fellabaum, D. Smith, and T. Brown Atypical Ductal Hyperplasia: Improved Accuracy with the 11-Gauge Vacuum-Assisted versus the 14-Gauge Core Biopsy Needle Ann. Surg. Oncol., September 1, 2007; 14(9): 2497 - 2501. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liberman, A. E. Holland, D. Marjan, M. P. Murray, L. Bartella, E. A. Morris, D. D. Dershaw, and R. T. Wynn Underestimation of Atypical Ductal Hyperplasia at MRI-Guided 9-Gauge Vacuum-Assisted Breast Biopsy Am. J. Roentgenol., March 1, 2007; 188(3): 684 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M F Dillon, C M Quinn, E W McDermott, A O'Doherty, N O'Higgins, and A D K Hill Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice. J. Clin. Pathol., July 1, 2006; 59(7): 740 - 743. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |